Literature DB >> 1348669

"False positive" perinuclear and cytoplasmic anti-neutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis.

A Davenport1.   

Abstract

The antineutrophil cytoplasmic antibody (ANCA) test has been shown to be important in helping to confirm the diagnosis and following the clinical course of microscopic polyarteritis and Wegener's granulomatosis. So called "false positive" test results have been reported, but usually in patients without any clinical evidence of these diseases, and the "false positive" result ignored. I wish to report 4 cases, in which a diagnosis of microscopic polyarteritis/Wegener's granulomatosis was considered as part of the differential diagnosis based on the clinical findings. The ANCA test was positive for cytoplasmic staining in 2 cases and perinuclear in 2 others. The combination of a positive ANCA result and the clinical possibility of Wegener's granulomatosis and/or microscopic polyarteritis resulted in the prescription of immunosuppressive treatment, with the consequent mortality of one patient and significant morbidity in two of the other cases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1348669

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  15 in total

Review 1.  Rare diseases.3: Wegener's granulomatosis.

Authors:  C A Langford; G S Hoffman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

Review 2.  ANCA testing. New developments and clinical implications.

Authors:  A E Ahmed; J B Peter; Y Y Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

3.  Anticytokeratins are a potential source of false-positive indirect immunofluorescence assays for C-ANCA.

Authors:  J Streicher; B Fabian; K Herkner; H Pointner; P M Bayer
Journal:  J Clin Lab Anal       Date:  1998       Impact factor: 2.352

4.  Clinical relevance of testing for antineutrophil cytoplasm antibodies (ANCA) with a standard indirect immunofluorescence ANCA test in patients with upper or lower respiratory tract symptoms.

Authors:  A Davenport; R J Lock; T B Wallington
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

Review 5.  Anti-neutrophil cytoplasmic autoantibodies (ANCA) and vasculitis.

Authors:  B Baslund; A Wiik
Journal:  Clin Rev Allergy       Date:  1994

Review 6.  The clinical relevance of ANCA in vasculitis.

Authors:  W L Gross; S Hauschild; N Mistry
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

7.  A review of immunofluorescent patterns associated with antineutrophil cytoplasmic antibodies (ANCA) and their differentiation from other antibodies.

Authors:  J A Savige; B Paspaliaris; R Silvestrini; D Davies; T Nikoloutsopoulos; A Sturgess; J Neil; W Pollock; K Dunster; M Hendle
Journal:  J Clin Pathol       Date:  1998-08       Impact factor: 3.411

Review 8.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

9.  Prevalence of antineutrophil cytoplasmic antibody positivity in patients with Hodgkin's and non-Hodgkin lymphoma: a single center experience.

Authors:  Timucin Cil; Abdullah Altintas; Abdurrahman Isikdogan; Sabri Batun
Journal:  Int J Hematol       Date:  2009-05-27       Impact factor: 2.490

10.  Wegener's granulomatosis overlapped with Takayasu arteritis.

Authors:  S Yamasaki; K Eguchi; Y Kawabe; T Tsukada; S Nagataki
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.